237 related articles for article (PubMed ID: 22011484)
21. Posterior to the ridge laser in zone 2 stage 3 retinopathy of prematurity with plus disease: Efficacy and safety.
Sanghi G; Gupta R; Narula S
Indian J Ophthalmol; 2023 Nov; 71(11):3501-3505. PubMed ID: 37870014
[TBL] [Abstract][Full Text] [Related]
22. One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.
Kıran Yenice E; Petriçli İS; Kara C
Int Ophthalmol; 2023 Jul; 43(7):2197-2202. PubMed ID: 36522564
[TBL] [Abstract][Full Text] [Related]
23. Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age.
Quinn GE; Dobson V; Davitt BV; Wallace DK; Hardy RJ; Tung B; Lai D; Good WV;
J AAPOS; 2013 Apr; 17(2):124-8. PubMed ID: 23622444
[TBL] [Abstract][Full Text] [Related]
24. Association between myopia progression and quantity of laser treatment for retinopathy of prematurity.
Hwang ES; Kassem IS; Allozi R; Kravets S; Al-Kirwi KY; Hallak JA; Costakos DM
PLoS One; 2022; 17(12):e0279898. PubMed ID: 36584135
[TBL] [Abstract][Full Text] [Related]
25. Refractive Status in Children with Laser-Treated Retinopathy of Prematurity: Our Experience in Bulgaria.
Veleva N; Chernodrinska V
Open Access Maced J Med Sci; 2019 Apr; 7(8):1320-1323. PubMed ID: 31110577
[TBL] [Abstract][Full Text] [Related]
26. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
Onofrey CB; Feuer WJ; Flynn JT
Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
[TBL] [Abstract][Full Text] [Related]
27. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.
Uparkar M; Sen P; Rawal A; Agarwal S; Khan B; Gopal L
Int Ophthalmol; 2011 Feb; 31(1):3-8. PubMed ID: 21194006
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization.
Bayramoglu SE; Sayin N
Int Ophthalmol; 2022 Oct; 42(10):3199-3210. PubMed ID: 35579771
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity.
Mori Y; Arima M; Ueda E; Fujiwara K; Seki E; Nakama T; Tsukamoto S; Akiyama M; Sonoda KH
Eye (Lond); 2021 Oct; 35(10):2820-2825. PubMed ID: 33257802
[TBL] [Abstract][Full Text] [Related]
30. Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity.
Pawar N; Somyashree D; Meenakshi R; Maheshwari D; Mohideen S; Sithiq Uduman M
Indian J Ophthalmol; 2023 Jun; 71(6):2561-2568. PubMed ID: 37322680
[TBL] [Abstract][Full Text] [Related]
31. Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.
Chou YB; Wang AG; Yang HY; Chen KJ; Yang CS
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3809-3816. PubMed ID: 35729410
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Refractive Error Changes in Retinopathy of Prematurity Patients Treated with Diode and Red Lasers.
Roohipoor R; Karkhaneh R; Riazi Esfahani M; Alipour F; Haghighat M; Ebrahimiadib N; Zarei M; Mehrdad R
Ophthalmologica; 2016; 235(3):173-8. PubMed ID: 26915028
[TBL] [Abstract][Full Text] [Related]
33. Incidence of cataract development by 6 months' corrected age in the Early Treatment for Retinopathy of Prematurity study.
Davitt BV; Christiansen SP; Hardy RJ; Tung B; Good WV;
J AAPOS; 2013 Feb; 17(1):49-53. PubMed ID: 23352719
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomized evaluation of diode-laser and cryotherapy in prethreshold retinopathy of prematurity.
Azad RV; Pasumala L; Kumar H; Talwar D; Pal R; Paul VK; Chandra P
Clin Exp Ophthalmol; 2004 Jun; 32(3):251-4. PubMed ID: 15180835
[TBL] [Abstract][Full Text] [Related]
35. Ocular growth pattern in cryotherapy- and laser-treated infants with prethreshold retinopathy of prematurity.
Azad RV; Lakshminarayana P; Kumar H; Talwar D; Pal N; Chandra P
J Pediatr Ophthalmol Strabismus; 2005; 42(3):149-54. PubMed ID: 15977867
[TBL] [Abstract][Full Text] [Related]
36. Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity.
Salgado CM; Celik Y; VanderVeen DK
Am J Ophthalmol; 2010 Jul; 150(1):6-9.e2. PubMed ID: 20227677
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation.
Wiecek E; Akula JD; Vanderveen DK; Mantagos IS; Wu C; Curran AL; De Bruyn H; Peterson B; Fulton AB
Am J Ophthalmol; 2022 Aug; 240():252-259. PubMed ID: 35367438
[TBL] [Abstract][Full Text] [Related]
38. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.
Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D
Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for early-onset high myopia after treatment for retinopathy of prematurity.
Matsumura S; Matsumoto T; Katayama Y; Tomita M; Morikawa H; Itokawa T; Kawakami M; Hori Y
Jpn J Ophthalmol; 2022 Jul; 66(4):386-393. PubMed ID: 35488107
[TBL] [Abstract][Full Text] [Related]
40. Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period.
Gunn DJ; Cartwright DW; Yuen SA; Gole GA
Clin Exp Ophthalmol; 2013 Mar; 41(2):159-66. PubMed ID: 22712637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
